Theranostics 2020; 10(7):3138-3150. doi:10.7150/thno.43441 This issue Cite

Research Paper

LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis

Ja-Hyun Koo1,2, Do-Hyun Kim1,2, Donghun Cha1,2, Min-Jong Kang3, Je-Min Choi1,2,4✉

1. Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea
2. Research Institute for Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea
3. Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
4. Research Institute for Convergence of Basic Sciences, Hanyang University, Seoul 04763, Republic of Korea

Citation:
Koo JH, Kim DH, Cha D, Kang MJ, Choi JM. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis. Theranostics 2020; 10(7):3138-3150. doi:10.7150/thno.43441. https://www.thno.org/v10p3138.htm
Other styles

File import instruction

Abstract

Graphic abstract

Multiple sclerosis (MS) is a demyelinating inflammatory disease of the central nervous system (CNS), which is a chronic progressive disease and is caused by uncontrolled activation of myelin antigen specific T cells. It has high unmet medical needs due to the difficulty of efficient drug delivery into the CNS to control tissue inflammation. In this study, we demonstrate that a fusion protein of NOD-like receptor family member X1 (NLRX1) and blood brain barrier (BBB)-permeable peptide, dNP2 ameliorates experimental autoimmune encephalomyelitis (EAE).

Methods: We purified recombinant LRR or NBD regions of NLRX1 protein conjugated with dNP2. To examine intracellular delivery efficiency of the recombinant protein, we incubated the proteins with Jurkat T cells or murine splenic T cells and their delivery efficiency was analyzed by flow cytometry. To investigate the therapeutic efficacy in an EAE model, we injected the recombinant protein into mice with 3 different treatment schemes e.g., prevention, semi-therapeutic, and therapeutic. To analyze their functional roles in T cells, we treated MACS-sorted naïve CD4 T cells with the proteins during their activation and differentiation into Th1, Th17, and Treg cells.

Results: dNP2-LRR protein treatment showed significantly higher delivery efficiency than TAT-LRR or LRR alone in Jurkat T cells and mouse splenic T cells. In all three treatment schemes of EAE experiments, dNP2-LRR administration showed ameliorated tissue inflammation and disease severity with reduced number of infiltrating T cells producing inflammatory cytokines such as IFNγ. In addition, dNP2-LRR inhibited T cell activation, cytokine production, and Th1 differentiation.

Conclusion: These results suggest that dNP2-LRR is a novel agent, which regulates effector T cell functions and could be a promising molecule for the treatment of CNS autoimmune diseases such as multiple sclerosis.

Keywords: NOD-like receptor family member X1, T cell, BBB-penetrating peptide, dNP2, experimental autoimmune encephalomyelitis


Citation styles

APA
Koo, J.H., Kim, D.H., Cha, D., Kang, M.J., Choi, J.M. (2020). LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis. Theranostics, 10(7), 3138-3150. https://doi.org/10.7150/thno.43441.

ACS
Koo, J.H.; Kim, D.H.; Cha, D.; Kang, M.J.; Choi, J.M. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis. Theranostics 2020, 10 (7), 3138-3150. DOI: 10.7150/thno.43441.

NLM
Koo JH, Kim DH, Cha D, Kang MJ, Choi JM. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis. Theranostics 2020; 10(7):3138-3150. doi:10.7150/thno.43441. https://www.thno.org/v10p3138.htm

CSE
Koo JH, Kim DH, Cha D, Kang MJ, Choi JM. 2020. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis. Theranostics. 10(7):3138-3150.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image